The government's move toward a fair-equals-cheap model of drug pricing may have long-term implications for patients and our health-care system.
The prime minister and his health minister, Ginette Petitpas Taylor, pictured speaking to reporters Dec. 5 in the House foyer after Question Period, ought to reconsider their recent stance on drug pricing, writes Life Sciences Ontario chief Jason Field. The Hill Times photograph by Andrew Meade
Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent.
People. Policy. Politics. This is an exclusive subscriber-only story.
Fostering use of Inuit languages was a key aim in creating Nunavut, but 20 years later, NTI president Aluki Kotierk says there's been a 'failure' when it comes to providing essential services to the public in Inuktut.